The results data showed that the decrease in the serum level of IL-21 was significantly correlated with the increase in the expression of IL-21R on the CD8+ T cells in the patients with DLBCL (P<0.001; Fig. 3). The gene discussed is IL21; the disease is diffuse large B-cell lymphoma.